StemCellPatents.com Newsletter

Hello ,

A paper was published last week in which adult bone marrow mesenchymal stem cells were transfected with the IGF-1 gene and used to treat animals after cardiac infarction.  Animals treated with the genetically modified stem cells exhibited better recovery as compared to controls recieving sham transfected cells.  Most interestingly, the authors demonstrated that the protective effect was associated with mobilization of endogenous stem cells. 

2 patents of interest to our field were recently issued.  The first #7,439,332 teaches a new polypeptide that stimulates erythropoiesis.  Perhaps most interesting about this patent was how they discovered the compound.  The second #7,439,064 is another one of Jamie Thomson's masterpieces, this time disclosing a serum-free, feeder-free method of maintaining embryonic stem cells in culture without spontaneous differentation.  The broadness of the first claim will strike you.

Potentiating Mesenchymal Stem Cells for Cardiac Regeneration Sunday October 26th, 2008 @ 12:13:01 EST Cincinnati, Ohio - Mesenchymal stem cells are attractive for therapeutics development because they can theoretically be used as a "one size fits all".  Additionally, their ability to home to area of tissue injury, in part by [Read More] 1 Comment Ask a question OR leave your comments. Read more StemCellPatents.com News

RMSC 2008 World Congress (2-4 December 2008)
The 3rd Annual Stem Cells World Congress (20-22 January 2009)
The Stem Cell Meeting (March 2009)

RECENTLY ADDED PATENTS     Mammary stem cell marker (7,563,619) Assignee | Inventor | Ask a question OR leave your comments     Soft tissue repair and regeneration using postpartum-derived cells (7,560,276) Assignee | Inventor | Ask a question OR leave your comments     Compositions and methods for generating skin (7,560,275) Assignee | Inventor | Ask a question OR leave your comments     Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease (7,560,102) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,560,280) Assignee | Inventor | Ask a question OR leave your comments     Human cord blood derived unrestricted somatic stem cells (USSC) (7,556,801) Assignee | Inventor | Ask a question OR leave your comments     Dedifferentiated, programmable stem cells of monocytic origin, and their production and use (7,553,663) Assignee | Inventor | Ask a question OR leave your comments     Stromal antigen-presenting cells and use thereof (7,553,661) Assignee | Inventor | Ask a question OR leave your comments     Directed in vitro differentiation of marrow stromal cells into neural cell progenitors (7,547,545) Assignee | Inventor | Ask a question OR leave your comments     Progenitor cells from wharton's jelly of human umbilical cord (7,547,546) Assignee | Inventor | Ask a question OR leave your comments     View all 1436 Stem Cell Patents on StemCellPatents.com

LATEST NEWS     Leptin Blocks T Regulatory Cell Expansion August 23rd, 2009     Mechanism of Multiple Sclerosis Stem Cell Therapy July 24th, 2009 : 2 Comments     Lithium for Treatment of Multiple Sclerosis July 15th, 2009     Treatment of Degenerative Disc Disease by Bone Marrow Stem Cells July 9th, 2009 : 2 Comments     Apoptotic Cells Secrete Angiogenic Factors June 27th, 2009     Read more news on StemCellPatents.com

LATEST JOBS POSTS     View the StemCellPatents.com Job Board

Thanks again for your help in supporting StemCellPatents.com.

We welcome your comments and suggestions! Tell us here.

Media Partnerships (NEW)

(BETA)